Corcept Therapeutics | CORT - Equity Capital And Reserves

Stock Price
56.37
Daily Change
-1.93 -3.31%
Monthly
28.23%
Yearly
-24.92%
Q2 Forecast
55.24

Corcept Therapeutics reported $637.99M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Acadia Pharmaceuticals USD 1.25B 20.68M Mar/2026
Alaunos Therapeutics USD 1.29M 865K Mar/2026
ANI Pharmaceuticals USD 562.3M 21.58M Mar/2026
Ardelyx USD 148.62M 18.33M Mar/2026
Assertio Holdings USD 105.8M 12.5M Sep/2025
Aurora Cannabis CAD 536.36M 30.74M Dec/2025
BioMarin Pharmaceutical USD 6.21B 125.11M Mar/2026
Bristol-Myers Squibb USD 20.07B 1.6B Mar/2026
Canopy Growth CAD 758.17M 22.16M Dec/2025
Corcept Therapeutics USD 637.99M 9.82M Mar/2026
Eli Lilly USD 31.2B 4.66B Mar/2026
Esperion Therapeutics USD -307.93M 5.97M Mar/2026
J&J USD 81.19B 358M Mar/2026
Knight Therapeutics CAD 767.27M 480K Dec/2025
Lexicon Pharmaceuticals USD 202.86M 95.32M Mar/2026
Merck USD 45.88B 6.73B Mar/2026
Nektar Therapeutics USD 89.83M 4.75M Dec/2025
Novartis USD 38.93B 7.2B Mar/2026
Novartis USD 46.13B 1.8B Dec/2025
Omeros USD -228.68M 15.13M Jun/2025
Pacira USD 653.89M 39.22M Mar/2026
Pfizer USD 90.1B 3.63B Mar/2026
Supernus Pharmaceuticals USD 1.08B 15.09M Mar/2026
TG Therapeutics USD 583.13M 64.89M Mar/2026